Avadel Pharmaceuticals plc (AVDL) |
| 13.879 -0.321 (-2.26%) 10-10 12:16 |
| Open: | 14.25 |
| High: | 14.25 |
| Low: | 13.83 |
| Volume: | 199,822 |
| Market Cap: | 1,339(M) |
| PE Ratio: | -693.95 |
| Exchange: | NASDAQ Global Market |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 16.37 |
| Resistance 1: | 15.47 |
| Pivot price: | 15.00 |
| Support 1: | 14.02 |
| Support 2: | 11.66 |
| 52w High: | 16.66 |
| 52w Low: | 6.38 |
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Financials
| EPS | -0.020 |
| Book Value | 0.940 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.041 |
| Profit Margin (%) | -1.32 |
| Operating Margin (%) | 13.04 |
| Return on Assets (ttm) | -1.2 |
| Return on Equity (ttm) | -3.6 |
Company news
Fri, 10 Oct 2025
Q3 Earnings Forecast for AVDL Issued By Leerink Partnrs - MarketBeat
Thu, 09 Oct 2025
Avadel Pharmaceuticals (NASDAQ:AVDL) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
Sun, 05 Oct 2025
Analysts Expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) To Breakeven Soon - Yahoo Finance
Tue, 30 Sep 2025
Avadel: Mispriced Leader In Once-Nightly Sleep Therapies - Seeking Alpha
Wed, 24 Sep 2025
Why The Story Around Avadel Pharmaceuticals Is Evolving After Recent Analyst and Market Updates - Sahm
Tue, 16 Sep 2025
$1.7 Million in Sleep Research Grants: How Avadel's 5-Year AASM Partnership is Transforming Sleep Medicine - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
